What happened
AprilBio updated the terms of convertible bonds to raise US$33.9M, about 11.3% of its market value.
For context, this raise equals about 11.3% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$33.9M |
| vs. market value | 11.3% |
| Filed | 2026-07-23, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260723000111 → open original filing |
Source: DART. Information only, not investment advice.